Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
EV/Core EBITDA

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 25.2531.8134.08--0.06

What is the latest EV/Core EBITDA ratio of CONCORD BIOTECH ?

The latest EV/Core EBITDA ratio of CONCORD BIOTECH is 25.25 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202625.25
Mar202531.81
Mar202434.08
Mar2023-
Mar2022-0.06

How is EV/Core EBITDA of CONCORD BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2026 25.25
-20.62
Mar2025 31.81
-6.66
Mar2024 34.08
0
Mar2023 0
100.00
Mar2022 -0.06 -

Other Financial Ratios of CONCORD BIOTECH


Compare EV/Core EBITDA ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹15,759.6 Cr 4.5% 3.7% -9.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

4.5%

3.7%

-9.8%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses